Decitabine (Dr.Reddy’s Laboratories Inc)


Welcome to the PulseAid listing for the Decitabine drug offered from Dr.Reddy’s Laboratories Inc. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Dr.Reddy’s Laboratories Inc
NON-PROPRIETARY NAME: Decitabine
SUBSTANCE NAME: DECITABINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-07-11
END MARKETING DATE: 0000-00-00


Decitabine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDecitabine from Dr.Reddy’s Laboratories Inc
LABELER NAME: Dr.Reddy’s Laboratories Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/50mL)
START MARKETING DATE: 2013-07-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 43598-348_bf9728a8-848d-9fdc-1647-f11a11b45758
PRODUCT NDC: 43598-348
APPLICATION NUMBER: ANDA203131

Other DECITABINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare Inc.Decitabine
Dr.Reddy’s Laboratories IncDecitabine
Dr.Reddy’s Laboratories LimitedDecitabine
Eisai Inc.Dacogen
Otsuka America Pharmaceutical, Inc.Dacogen
Sandoz IncDecitabine